The Michigan Society of Hematology and Oncology’s Post

Focusing on the KPIs That Matter: Tips and tricks for selecting and influencing the factors that will drive your practice to provide higher quality care As business administrators working in hematology/oncology, our mission should always be to provide the highest quality care to as many patients as possible. While this is a lofty goal that can be subjective in some ways, there are objective measures and tactics that can be tied to assessing success. Read the full article here! Read the latest Practice Management Institute / The Michigan Society of Hematology and Oncology article in the August issue of Oncology Practice Management magazine, written by Jason Lockard, MBA, Director, Operations - Pediatric Specialty Corewell Health Medical Group East- great article, Jason!

Karen Fancher, PharmD, BCOP, shares insights from her presentation at the HOPA Annual Conference 2024, delving into the ethical complexities faced by oncology pharmacists. From balancing beneficence and non-maleficence to navigating drug shortages, her discussion sheds light on crucial considerations in patient care. Read more about the intersection of science and morals in oncology pharmacy: https://lnkd.in/gpJWG9ZP #OncologyPharmacy #EthicalDilemmas #HealthcareEthics #PharmacyNews

I am thrilled to announce that I have successfully completed the Oncology Pharmacy course. This program has provided me with advanced knowledge and practical skills essential for effectively managing oncology patients and their complex medication regimens. Throughout the course, I gained in-depth insights into several critical topics, including: - Chemotherapy preparation and dosage calculations - Adjusting chemotherapy doses based on lab results - Outpatient and inpatient handling of oncology patients - Patient education and comprehensive medication history taking - Managing chemotherapy-induced complications and providing supportive care - Bone Marrow Transplantation (BMT) protocols and procedures - Identifying and categorizing medication errors in oncology settings - Understanding different types of emesis and utilizing various anti-emetic medications - Categorizing intravenous and oral chemotherapy medications based on their emetogenic potential I would like to extend my heartfelt thanks to Dr. Nada Adel for her exceptional guidance and instruction throughout this course. I am excited to apply the knowledge and skills gained from this course to the practical field and contribute meaningfully to the healthcare industry. #OncologyPharmacy #PharmaceuticalCare #Chemotherapy #PatientCare #MedicationSafety #ProfessionalDevelopment

Unique Oncology Center Model Fully Integrates, Empowers Pharmacists: The model implemented at City of Hope Chicago has been shown to improve provider workloads and enrich pharmacists’ work. #finance #pharmacy #lifesciences

Becoming an oncology Clinical Pharmacist 💡Pharmacists collaborate with the healthcare team to clarify chemotherapy orders against treatment protocols, guidelines📖,and patient-specific factors to identify any discrepancies and make necessary adjustments and provide recommendations for optimizing therapy. ⏩As a part of healthcare team pharmacists 💥Key🗝️ role in Chemotherapy Order Verification 📝 and Review💯 📢Do you want to know more about Chemotherapy Order Verification and Review❓ ▶️ Stay tuned if u🙋 want to learn oncology and transform yourself into an oncology Clinical Pharmacist #oncology #clinicalpharmacy #training #pharmd #clinicalpharmacist #pharmacypractice #careeradvancement #residencyprogram #fellowship Dr.Pravallika Vutukuru Chris Elder, PharmD, BCOP Manoj Kumar Yadava

Focusing on patient needs and outcomes is vital for success in any VBC program!

𝐎𝐮𝐭𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2032/Global Insight Services The global Outpatient Oncology Infusion Market was valued at USD 62.5 billion in 2022, and it is anticipated to grow to USD 205.3 billion by 2032, at a CAGR of 12.4% during the forecast period. The outpatient oncology infusion centers offer a variety of treatments, such as chemotherapy, blood transfusions, platelet transfusions, IV antibiotics, and hydration and electrolyte replacement. It also provides long-term and short-infusion therapy to patients in an appropriate manner. Visit the following link to request free sample pages https://lnkd.in/e2zwDEaj #cancertreatment #oncology #outpatientoncologyinfusionmarket #outpatientoncologyinfusion #marketanalysis #marketresearchreport #chemotherapy #healthcare 𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 BKK B. Braun Melsungen AG Baxter International Inc. BD Fresenius Kabi, ICU Medical IRadimed Corporation Nipro Medical Corporation Terumo Medical Corporation Smiths Medical Medtronic Teleflex

💡 In an interview with Pharmacy Times® at the Community Oncology Alliance (COA) 2024 Payer Exchange, Lalan Wilfong, M.D., medical oncologist at Thyme Care, emphasizes how value-based care (VBC) in oncology centers around one key principle: putting the patient first. He also explains how understanding each patient's unique needs is critical to delivering personalized care while managing costs. Collaboration between payers and providers is essential to align incentives and improve outcomes. Despite challenges like inflation impacting access to care, innovations in drug therapies and AI offer hope for the future of VBC. Learn more about Dr. Wilfong’s vision for the future of oncology care here: https://lnkd.in/e6awm7x2

The global Diagnostic Radiopharmaceuticals market was valued at US$ 4385.1 million in 2023 and is anticipated to reach US$ 7034 million by 2030 witnessing a CAGR of 6.9% during the forecast period 20242030. North America is the worlds major consumer region with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region accounting for 24.5% of the global market. #DiagnosticRadiopharmaceuticals #GlobalMarket #HealthcareIndustry #MedicalImaging #Technetium99 #Fluorine18 #Oncology #Cardiology #NorthAmerica #Europe

Bridging Clinical Research and Pharmacy Practice: The Evolving Role of Oncology Pharmacists: Scott Soefje highlights how oncology pharmacists can advance patient-centered care and drive innovation in clinical research. #finance #pharmacy #lifesciences